EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors

Nektaria Papadopoulou-Marketou, Marina Tsoli iD, Eleftherios Chatzellis iD, Krystallenia I Alexandraki iD, Gregory Kaltsas

Cancers · 30.05.2024 · 16 (11) · 2075

DOI: 10.3390/cancers16112075 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.05.2024. Verfasst von Nektaria Papadopoulou-Marketou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neuroendocrine Tumor Unit, EURACAN 4 and ENETS Centre of Excellence, 1st Department of Propaedeutic Internal Medicine, Laiko General Hospital, Nation…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic neuroendocrine tumors (PanNETs) and lung NETs (LNETs) represent a rare but clinically significant subgroup of neoplasms. While the majority is sporadic, approximately 17% of PanNETs and a subset of LNETs develop in the context of monogenic familial tumor syndromes, especially multiple endocrine neoplasia type 1 (MEN1) syndrome. Other inherited syndromes associated with PanNETs include MEN4, von Hippel–Lindau (VHL) syndrome, neurofibromatosis type 1 (NF1), and tuberous sclerosis complex (TSC). These syndromes are highly penetrant and their clinical manifestations may vary even among members of the same family. They are attributed to genetic mutations involving key molecular pathways regulating cell growth, differentiation, and angiogenesis. Pancreatic NETs in hereditary syndromes are often multiple, develop at a younger age compared to sporadic tumors, and are associated with endocrine and nonendocrine tumors derived from multiple organs. Lung NETs are not as common as PanNETs and are mostly encountered in MEN1 syndrome and include typical and atypical lung carcinoids. Early detection of PanNETs and LNETs related to inherited syndromes is crucial, and specific follow-up protocols need to be employed to optimize diagnosis and management. Genetic screening is recommended in childhood, and diagnostic screening starts often in adolescence, even in asymptomatic mutation carriers. Optimal management and therapeutic decisions should be made in the context of a multidisciplinary team in specialized centers, whereas specific biomarkers aiming to identify patients denoted to follow a more aggressive course need to be developed.

Schlagwörter

Stichwörter der Autor:innen

MEN1hereditary syndromeslung neuroendocrine tumorspancreatic neuroendocrine tumors

Autor:innen und Institutionen

  • Neuroendocrine Tumor Unit, EURACAN 4 and ENETS Centre of Excellence, 1st Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • 251 Air Force General Hospital, 11525 Athens, Greece.
  • 2nd Department of Surgery, Aretaieio Hospital Athens, Medical School, 11528 Athens, Greece.

ORCID-Profile: Marina Tsoli, Eleftherios Chatzellis, Krystallenia I Alexandraki

Zitieren

APA

Papadopoulou-Marketou, N., Tsoli, M., Chatzellis, E., Alexandraki, K. I., & Kaltsas, G. (2024). Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors. Cancers, 16(11), 2075. https://doi.org/10.3390/cancers16112075

Vancouver

Papadopoulou-Marketou N, Tsoli M, Chatzellis E, Alexandraki KI, Kaltsas G. Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors. Cancers. 2024;16(11):2075. doi:10.3390/cancers16112075

BibTeX
@article{PapadopoulouMarketou2024,
  author = {Papadopoulou-Marketou, Nektaria and Tsoli, Marina and Chatzellis, Eleftherios and Alexandraki, Krystallenia I and Kaltsas, Gregory},
  title = {Hereditary Syndromes Associated with Pancreatic and Lung Neuroendocrine Tumors},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {2075},
  doi = {10.3390/cancers16112075}
}
Kostenlos starten →